Attard, Gerhardt
Antonarakis, Emmanuel S.
Article History
First Online: 2 November 2016
Competing interests
: G.A. has received honoraria, consulting fees or travel support from Astellas, Medivation, Janssen, Millennium Pharmaceuticals, Ipsen, Ventana, Bayer, Essa Pharma, Abbott Labs, Novartis, Veridex and Sanofi-Aventis, and grant support from Janssen, AstraZeneca, Innocrin and Arno. The Institute of Cancer Research (ICR) developed abiraterone and, therefore, has a commercial interest in this agent. G.A. is on the ICR list of rewards to inventors for abiraterone. E.S.A. has served as a paid consultant and/or adviser for Janssen, Astellas, Essa, and Medivation; has received research funding to his institution from Janssen, Johnson & Johnson, Medivation, and Tokai; and is a coinventor of a biomarker technology that has been licensed to Tokai.